查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1546283

全球血型检验市场：依产品类型、测试类型、方法、最终使用者、地区、机会、预测，2017-2031年

Blood Group Typing Market Assessment, By Product, By Test Type, By Technique, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 251 Pages | 商品交期: 3-5个工作天内

价格

2024-2031年预测期间，全球血型检验市场规模将以9.09%的年复合成长率扩大，从2023年的21.07亿美元成长到2031年的42.2614亿美元。由于输血意识的提高和血液检验需求的增加，预计血型分型相关产品类型将在预测期内呈指数级成长。

血型检验包括识别个体血型、抗原和抗体的测试。用于血型分型的产品类型，如设备、试剂盒、试剂和消耗品，由于多种成长因素推动市场发展，包括全球捐血和输血程序的增加以及製程自动化程度的提高。由于用于 HLA 分型等程序的新技术、人工智慧的引进、对更快工作速度的高通量设备的需求不断成长以及许多其他因素，预计该市场将显着成长。市场领导者的努力，如策略性产品发布、批准和其他市场策略，预计将有助于市场在预测期内的进一步成长。

全球输血和捐血程序的增加对血型分型产品的需求产生了重大影响。随着捐血数量的增加，对有效的血型检验产品的需求也增加。血型分型对于确保安全和相容的输血以及降低副作用和感染的风险非常重要。需要定期输血的患者（例如患有地中海贫血或镰状细胞性贫血的患者）对紧密匹配的血型的需求特别高。这些需求需要强大的血型系统来确保在需要时提供适当的血型。随着捐血意识的增强，越来越多的人定期捐血。所有这些因素都反映出血型分型市场的光明前景。例如，根据美国疾病管制与预防中心2024年2月发布的资料，美国每年约有700万名捐血者和超过1,400万单位的输血。

本报告调查了全球血型定型市场，包括市场概述、依产品类型、测试类型、方法、最终用户、地区的趋势，以及进入市场的市场的公司概况。

目录

第1章 专案范围与定义

第2章 研究方法

第3章 执行摘要

第4章 2017-2031年全球血型分型市场展望

  • 市场规模分析与预测
  • 市占率分析与预测
  • 2023年市场地图分析
    • 依产品
    • 依测试类型
    • 依方法
    • 依最终用户
    • 依地区

第5章 北美血型分型市场展望，2017-2031

第6章 欧洲血型分型市场展望，2017-2031

第7章 亚太地区血型分型市场展望，2017-2031

第8章 南美洲血型分型市场展望，2017-2031

第9章 中东与非洲血型分型市场展望，2017-2031年

第10章 供需分析

第11章 进出口分析

第12章 价值链分析

第13章 波特五力分析

第14章 PESTLE分析

第15章 价格分析

第16章 市场动态

第17章 市场趋势与发展

第18章 监理架构与创新

第19章 专利状况

第20章 个案研究

第21章 竞争态势

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名进入公司的SWOT 分析
  • 市场前10位主要参与者的情况
    • Werfen, S.A.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Beckman Coulter, Inc. (Danaher Corporation)
    • Grifols, S.A.
    • Agena Bioscience, Inc.
    • Illumina Inc.
    • QIAGEN N.V.
    • QuidelOrtho Corporation

第22章 策略建议

第23章 查询及免责声明

Product Code: MX11833

Global blood group typing market is projected to witness a CAGR of 9.09% during the forecast period 2024-2031, growing from USD 2107 million in 2023 to USD 4226.14 million in 2031. The market for products associated with blood group typing is anticipated to grow exponentially in the forecast period owing to rising awareness about blood transfusions and increasing demand for blood testing.

Blood group typing involves tests to identify the blood group, antigen, and antibody present in an individual. The market for products used for blood group typing, such as instruments, kits, reagents, and consumables, is driven by several growing factors, such as increasing blood donations and transfusion procedures across the globe and the involvement of automation in the process. The market is anticipated to register significant growth due to novel technologies used for such procedures as HLA typing, inculcation of artificial intelligence, heightened demand for high-throughput instruments to work at a faster pace, and many more. The efforts of market leaders, such as strategic product launches, approvals, and other market tactics are anticipated to help in further growth of the market in the forecast period.

For instance, in April 2024, Grifols, S.A. launched its leading blood-typing technology, the automated Erytra Eflexis, in the Chinese market after regulatory approval. The system uses "load-and-go" automation to rapidly perform complex blood-typing analytics and is designed to enhance pretransfusion compatibility testing. Using Grifols' DG gel technology confirms blood-group compatibility through the presence or absence of different red-blood antigens and antibodies. The Erytra Eflexis optimizes workflow efficiency and can be tailored to various lab configurations and processing needs, providing reliable, timely results.

Rising Blood Transfusion and Donation Procedures Across the Globe

The global increase in blood transfusion and donation procedures significantly impacts the demand for blood group typing products. As the number of blood donations rises, so does the need for effective blood group typing products. Blood group typing is essential for ensuring safe and compatible transfusions, reducing the risk of adverse reactions and infections. The demand for closely matched blood types is particularly high among patients requiring regular transfusions, such as those with thalassemia or sickle cell anemia. This demand necessitates a robust system for blood typing to ensure that the right blood type is available when needed. The demographic profile of blood donors is also changing; with increasing awareness of blood donations, more people are donating blood on a regular basis. All these factors reflect a promising future for the blood group typing market. For instance, as per data published by the Centers for Disease Control and Prevention in February 2024, there are approximately 7 million blood donors, and more than 14 million units of blood transfused annually in the United States.

Shift Towards Automated Blood Group Typing Techniques

The shift towards automated blood group typing techniques is reshaping the demand for blood group typing products, driven primarily by the adoption of molecular typing methods. These methods, including PCR, microarray, and next-generation sequencing, are becoming increasingly prevalent due to their ability to provide highly accurate and rapid results, even in complex cases such as recently transfused patients or those with autoantibodies. Automated molecular techniques offer significant advantages over traditional serological methods, such as they can detect rare, weak, and variant blood group antigens, providing faster turnaround times and delivering increased sensitivity and specificity. For instance, in June 2024, Innobiochips launched Omnys, a cutting-edge automated blood grouping and testing system designed to enhance lab productivity and reduce environmental impact. Omnys utilizes exclusive technologies to enable multiplex testing with unparalleled precision, reliability, and efficiency using minimal sample volumes. It can perform up to 10 tests per well, offering ultimate blood compatibility and expanded sample characterization without additional costs. Such innovation in the market is anticipated to drive notable growth.

Rapid Growth of the HLA Typing Segment

The HLA typing segment is anticipated to register the highest CAGR in the blood group typing market. The rapid growth of HLA typing has transformed transplant and transfusion procedures, evolving from serological methods to advanced molecular techniques like sequence-based typing. While distinct from blood group typing, advancements in HLA typing have positively influenced blood group methods. Molecular techniques such as PCR have improved the reliability of blood group antigen identification, particularly for patients with rare types or specific antibodies. The strategic product launches by players in recent times for catering HLA typing segment further enhance its market share. For instance, in April 2023, Metropolis Healthcare Limited introduced the "NextGen HLA" Typing Test, which utilizes the advanced molecular technology called 'Next Generation Sequencing (NGS)'. The NextGen HLA Typing test is a highly detailed molecular test performed for Hematopoietic Stem Cell Transplant (HSCT) and solid organ transplantation. This test helps in identifying a suitable donor for bone marrow, cord blood, or organ transplant by analyzing the Human Leukocyte Antigen (HLA) genes inherited from the parents.

North America Dominates Blood Group Typing Market

North America is anticipated to account for the largest share of the blood group typing market in 2023, driven by a robust healthcare infrastructure and significant investments in research and development (R&D) of innovative diagnostic techniques. The presence of a large number of blood banks and laboratories, a high number of transfusions performed, and favorable reimbursement scenarios in the region support the robust growth of the market. For instance, according to the American Red Cross Society, nearly 16 million blood components are transfused each year in the United States. Apart from that, the presence of several major players in the United States market further boosts the market share. Increased blood donation awareness collectively positions North America as the dominant region in consuming blood group typing products. This trend is expected to continue, with the market projected to grow significantly in the coming years.

Future Market Scenario (2024-2031F)

High-throughput DNA-based genotyping techniques are revolutionizing the blood group typing market. It offers several advantages over traditional serological methods for efficiently testing blood groups. DNA genotyping allows for the testing of thousands of samples per run, making it highly scalable for screening large donor populations, which is much more efficient than the laborious and expensive process of serologically typing large donor populations. High-throughput genotyping platforms like DNA arrays enable rapid, comprehensive, and cost-effective blood group testing of large donor populations, facilitating the identification of rare phenotypes and better matching between recipients and donors to improve transfusion safety and efficiency. For instance, in May 2024, Thermo Fisher Scientific Inc. introduced the Applied Biosystems Axiom BloodGenomiX Array and Software, a solution for precise blood genotyping in clinical research. The new array detects extended and rare blood groups, tissue (HLA), and platelet (HPA) types in a single, high-throughput assay, supporting advancements in donor blood matching for extended phenotypes.

Key Players Landscape and Outlook

Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Beckman Coulter, Inc. (Danaher Corporation), Grifols, S.A., Agena Bioscience, Inc., Illumina Inc., QIAGEN N.V., Werfen, S.A., QuidelOrtho Corporation are some of the leading market players active in global blood group typing market. Significant market activities reported in recent times include distribution agreements and acquisitions alongside several product launches. The market players are actively showing interest in market developments to enhance the growth rate.

In June 2023, AliveDx (formerly Quotient) and TransMedics Group, Inc. signed a distribution agreement, allowing TransMedics to distribute Alba by Quotient and MosaiQ in five Southeast Asian countries. This partnership reinforces Quotient's commitment to expanding its geographical presence and enhancing regional patient care. TransMedics, a leader in medical technology in Southeast Asia, will be distributing these products as part of their regional operations.

In March 2023, Werfen, S.A. completed the acquisition of Immucor, Inc., a United States-based company in the diagnostics sector. The acquisition was priced at USD 2 billion and will expand Werfen's presence in the specialized diagnostics market, including the blood group type segment. The combined revenues are expected to exceed USD 2.45 billion, and the company is expected to have seven technology centers and employ more than 7,000 people worldwide following this acquisition.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Blood Group Typing Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Consumables
      • 4.2.1.2. Kits
      • 4.2.1.3. Instruments
    • 4.2.2. By Test Type
      • 4.2.2.1. ABO Tests
      • 4.2.2.2. Antigen Typing
      • 4.2.2.3. Antibody Screening
      • 4.2.2.4. Cross-Matching Tests
      • 4.2.2.5. HLA Typing
    • 4.2.3. By Technique
      • 4.2.3.1. Serological Tests
      • 4.2.3.2. Molecular Tests
        • 4.2.3.2.1. PCR
        • 4.2.3.2.2. Microarray
        • 4.2.3.2.3. Next Generation Sequencing
        • 4.2.3.2.4. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Blood Banks
      • 4.2.4.3. Independent Laboratories
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Test Type
    • 4.3.3. By Technique
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Blood Group Typing Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Consumables
      • 5.2.1.2. Kits
      • 5.2.1.3. Instruments
    • 5.2.2. By Test Type
      • 5.2.2.1. ABO Tests
      • 5.2.2.2. Antigen Typing
      • 5.2.2.3. Antibody Screening
      • 5.2.2.4. Cross-Matching Tests
      • 5.2.2.5. HLA Typing
    • 5.2.3. By Technique
      • 5.2.3.1. Serological Tests
      • 5.2.3.2. Molecular Tests
        • 5.2.3.2.1. PCR
        • 5.2.3.2.2. Microarray
        • 5.2.3.2.3. Next Generation Sequencing
        • 5.2.3.2.4. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Blood Banks
      • 5.2.4.3. Independent Laboratories
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Blood Group Typing Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Consumables
          • 5.3.1.2.1.2. Kits
          • 5.3.1.2.1.3. Instruments
        • 5.3.1.2.2. By Test Type
          • 5.3.1.2.2.1. ABO Tests
          • 5.3.1.2.2.2. Antigen Typing
          • 5.3.1.2.2.3. Antibody Screening
          • 5.3.1.2.2.4. Cross-Matching Tests
          • 5.3.1.2.2.5. HLA Typing
        • 5.3.1.2.3. By Technique
          • 5.3.1.2.3.1. Serological Tests
          • 5.3.1.2.3.2. Molecular Tests
          • 5.3.1.2.3.2.1. PCR
          • 5.3.1.2.3.2.2. Microarray
          • 5.3.1.2.3.2.3. Next Generation Sequencing
          • 5.3.1.2.3.2.4. Others
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals
          • 5.3.1.2.4.2. Blood Banks
          • 5.3.1.2.4.3. Independent Laboratories
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Blood Group Typing Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Blood Group Typing Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Blood Group Typing Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Blood Group Typing Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Werfen, S.A.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 21.3.2. Bio-Rad Laboratories, Inc.
    • 21.3.3. Thermo Fisher Scientific Inc.
    • 21.3.4. Merck KGaA
    • 21.3.5. Beckman Coulter, Inc. (Danaher Corporation)
    • 21.3.6. Grifols, S.A.
    • 21.3.7. Agena Bioscience, Inc.
    • 21.3.8. Illumina Inc.
    • 21.3.9. QIAGEN N.V.
    • 21.3.10. QuidelOrtho Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 5. Global Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 6. Global Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Blood Group Typing Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 9. North America Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 12. North America Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 13. North America Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Blood Group Typing Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 16. United States Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 19. United States Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 20. United States Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 22. Canada Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 25. Canada Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 26. Canada Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 28. Mexico Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 31. Mexico Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 32. Mexico Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 34. Europe Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 37. Europe Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 38. Europe Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Blood Group Typing Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 41. Germany Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 44. Germany Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 45. Germany Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 47. France Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 49. France Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 50. France Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 51. France Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 53. Italy Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 56. Italy Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 57. Italy Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 59. United Kingdom Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 62. United Kingdom Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 63. United Kingdom Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 65. Russia Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 68. Russia Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 69. Russia Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 71. Netherlands Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 74. Netherlands Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 75. Netherlands Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 77. Spain Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 80. Spain Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 81. Spain Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 83. Turkey Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 86. Turkey Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 87. Turkey Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 89. Poland Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 92. Poland Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 93. Poland Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 95. South America Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 98. South America Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 99. South America Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Blood Group Typing Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 102. Brazil Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 105. Brazil Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 106. Brazil Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 108. Argentina Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 111. Argentina Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 112. Argentina Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 114. Asia-Pacific Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 117. Asia-Pacific Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 118. Asia-Pacific Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Blood Group Typing Market Share (%), By Country, 2017-2031F
  • Figure 120. India Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 121. India Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 123. India Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 124. India Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 125. India Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 127. China Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 129. China Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 130. China Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 131. China Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 133. Japan Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 136. Japan Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 137. Japan Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 139. Australia Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 142. Australia Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 143. Australia Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 145. Vietnam Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 148. Vietnam Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 149. Vietnam Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 151. South Korea Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 154. South Korea Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 155. South Korea Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 157. Indonesia Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 160. Indonesia Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 161. Indonesia Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 163. Philippines Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 166. Philippines Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 167. Philippines Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 169. Middle East & Africa Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 172. Middle East & Africa Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 173. Middle East & Africa Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Blood Group Typing Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 176. Saudi Arabia Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 179. Saudi Arabia Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 180. Saudi Arabia Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 182. UAE Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 185. UAE Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 186. UAE Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Blood Group Typing Market, By Value, In USD Million, 2017-2031F
  • Figure 188. South Africa Blood Group Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Blood Group Typing Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Blood Group Typing Market Share (%), By Test Type, 2017-2031F
  • Figure 191. South Africa Blood Group Typing Market Share (%), By Technique, 2017-2031F
  • Figure 192. South Africa Blood Group Typing Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194. By Test Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195. By Technique Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023